drugset / Trial / NCT00989391

A Study In Healthy People To Investigate The Safety, Toleration And Time Course Of Blood Concentrations Of Multiple Doses Of PF-03654764, Given By Mouth

NCT00989391

Phase 1 Completed 36 enrolled Pfizer
RandomizedParallel-groupDouble-blindBasic science

Summary

The purpose of this study in heathy people is to investigate the safety, toleration and time course of PF-03654764 in the blood, following multiple doses given once or twice daily by mouth for 10 days.

Timeline

Start
2009-10
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-03654764 Small molecule 5 mg Oral
Subject PF-03654764 Small molecule 12 mg Oral

Indications

No indication recorded.